ITHEMYC consortium

The ITHEMYC consortium consists of 11 partners, bringing together the different kinds of expertise needed for this multidisciplinary project and located in seven different countries.

Consortium partners:

  • TuBerculosis Vaccine Initiative (TBVI) (Coordinator)
  • GSK (GSK)
  • Centre National de la Recherche Scientifique (CNRS)
  • Université Paul Sabatier – Toulouse III (UPS)
  • Global Alliance for TB Drug Development (TB Alliance)
  • Instituto de Investigación Germans Trias i Pujol (IGTP)
  • Università degli Studi di Catania (UNICT)
  • Alma Mater Studiorum – Università di Bologna (UNIBO)
  • Johns Hopkins University (JHU)
  • Tel-Aviv University (TAU)
  • Department of Health (UKHSA)